Real-World Improvements of Lung Clearance Index and Ventilation Distribution Efficiency in Children With Cystic Fibrosis After Elexacaftor/Tezacaftor/Ivacaftor Initiation.

Pediatr Pulmonol · 2025 · PMC12180290 · PMID 40539675

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

5.1 Effectiveness of ETI The fact that ETI is a potent treatment in CF is shown in several studies including the present, with highly significant improvements in lung function overall and in all subgroups.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.